Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
The Netherlands Journal of Medicine
|
August 1, 1991
Riedel's thyroiditis in a patient with retroperitoneal fibrosis
W H Kruit, G J den Ottolander
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
Interferon-alpha induced Raynaud's syndrome
W H Kruit, A M Eggermont, G Stoter
Cancer Immunology, Immunotherapy : CII
|
September 4, 1999
The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells
W H Kruit, P I Schmitz, G Stoter
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
January 1, 1984
Haptoglobin typing, is it clinically necessary for a reliable determination of haptoglobin with the single radial immunodiffusion technique?
H J van Rijn, W H Kruit, J Schrijver
Nederlands Tijdschrift Voor Geneeskunde
|
August 12, 1999
[Side effects of interferon alfa]
L Berk, A R van Gool, M Bannink, et al.
Journal of Internal Medicine
|
October 1, 1991
The significance of venography in the management of patients with clinically suspected pulmonary embolism
W H Kruit, A C de Boer, A K Sing, et al.
European Journal of Clinical Investigation
|
April 12, 2000
Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response
T C Stam, A J Swaak, W H Kruit, et al.
British Journal of Cancer
|
November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients
R de Wit, W H Kruit, G Stoter, et al.
Acta Neuropsychiatrica
|
March 16, 2016
Management of psychiatric adverse events with immunotherapy with interferon-alfa
A R Van Gool, W H Kruit, J J Cornelissen, et al.
Journal of the National Cancer Institute
|
October 2, 1996
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support
R de Wit, J Verweij, M Bontenbal, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
The Netherlands Journal of Medicine
|
August 1, 1991
Riedel's thyroiditis in a patient with retroperitoneal fibrosis
W H Kruit, G J den Ottolander
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 6, 2001
Interferon-alpha induced Raynaud's syndrome
W H Kruit, A M Eggermont, G Stoter
Cancer Immunology, Immunotherapy : CII
|
September 4, 1999
The role of possible risk factors for acute and late renal dysfunction after high-dose interleukin-2, interferon alpha and lymphokine-activated killer cells
W H Kruit, P I Schmitz, G Stoter
Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Fur Klinische Chemie Und Klinische Biochemie
|
January 1, 1984
Haptoglobin typing, is it clinically necessary for a reliable determination of haptoglobin with the single radial immunodiffusion technique?
H J van Rijn, W H Kruit, J Schrijver
Nederlands Tijdschrift Voor Geneeskunde
|
August 12, 1999
[Side effects of interferon alfa]
L Berk, A R van Gool, M Bannink, et al.
Journal of Internal Medicine
|
October 1, 1991
The significance of venography in the management of patients with clinically suspected pulmonary embolism
W H Kruit, A C de Boer, A K Sing, et al.
European Journal of Clinical Investigation
|
April 12, 2000
Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein response
T C Stam, A J Swaak, W H Kruit, et al.
British Journal of Cancer
|
November 21, 1998
Docetaxel (Taxotere): an active agent in metastatic urothelial cancer; results of a phase II study in non-chemotherapy-pretreated patients
R de Wit, W H Kruit, G Stoter, et al.
Acta Neuropsychiatrica
|
March 16, 2016
Management of psychiatric adverse events with immunotherapy with interferon-alfa
A R Van Gool, W H Kruit, J J Cornelissen, et al.
Journal of the National Cancer Institute
|
October 2, 1996
Adverse effect on bone marrow protection of prechemotherapy granulocyte colony-stimulating factor support
R de Wit, J Verweij, M Bontenbal, et al.
Page
of 3